SGMO - Financial Reports List - Sangamo Therapeutics, Inc. - IntrinsicAlpha

Sangamo Therapeutics, Inc. SGMO

Healthcare - Biotechnology - NASDAQ - US

$ 0.7452

4.31 %

$ 167 M

Market Cap

-1.5

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	269.78%	61.20%	58.32%
Annual Report	FY	10-K	2024-12-31	-67.20%	62.01%	62.06%
Quarterly Report	Q3	8-K	2024-09-30	425.77%	110.25%	109.99%
Quarterly Report	Q2	8-K	2024-06-30	-94.79%	68.45%	69.99%
Quarterly Report	Q1	8-K	2024-03-31	-99.70%	-232.29%	-33.57%
Quarterly Report	Q4	8-K	2023-12-31	-92.50%	-16.01%	-12.58%
Annual Report	FY	10-K	2023-12-31	58.34%	-34.09%	-36.13%
Quarterly Report	Q3	8-K	2023-09-30	-64.48%	-95.96%	-93.84%
Quarterly Report	Q2	8-K	2023-06-30	-76.73%	-165.23%	-170.20%
Quarterly Report	Q1	8-K	2023-03-31	459.52%	148.05%	398.66%

1